Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1530297rdf:typepubmed:Citationlld:pubmed
pubmed-article:1530297lifeskim:mentionsumls-concept:C0023884lld:lifeskim
pubmed-article:1530297lifeskim:mentionsumls-concept:C0205054lld:lifeskim
pubmed-article:1530297lifeskim:mentionsumls-concept:C0494165lld:lifeskim
pubmed-article:1530297lifeskim:mentionsumls-concept:C1609982lld:lifeskim
pubmed-article:1530297lifeskim:mentionsumls-concept:C0728940lld:lifeskim
pubmed-article:1530297lifeskim:mentionsumls-concept:C1527249lld:lifeskim
pubmed-article:1530297lifeskim:mentionsumls-concept:C0034897lld:lifeskim
pubmed-article:1530297lifeskim:mentionsumls-concept:C1561577lld:lifeskim
pubmed-article:1530297lifeskim:mentionsumls-concept:C1514811lld:lifeskim
pubmed-article:1530297lifeskim:mentionsumls-concept:C1706462lld:lifeskim
pubmed-article:1530297pubmed:issue10 Suppllld:pubmed
pubmed-article:1530297pubmed:dateCreated1992-10-20lld:pubmed
pubmed-article:1530297pubmed:abstractTextIn the patients with liver metastases of colorectal cancer, pre-and post operative intra-arterial infusion chemotherapy was evaluated for prevention of recurrence in the residual liver after hepatic resection. Materials are sixty-five hepatectomized patients from May 1981 to 1992. Therapies were subdivided into five groups. I: pre-and postoperative non-therapy (n = 3); II: postoperative chemotherapy (n = 22); III: postoperative intra-arterial infusion chemotherapy (n = 12); IV: pre-operative intra-arterial infusion chemotherapy + postoperative chemotherapy (n = 15); and V: pre-and postoperative intra-arterial infusion chemotherapy (n = 13). In recurrence rate in the residual liver, I to IV groups showed as high as 50-100%. However, the disease-free survival rate was 100% in V group, revealing a significant difference between the other four groups. Accordingly, in order to prevent recurrence in the residual liver of hepatectomized patients with liver metastases of colorectal cancer and prolong the disease-free interval, we consider that pre-and post-operative intra-arterial infusion chemotherapy can be effective, compared to pre-or postoperative intra-arterial infusion chemotherapy alone.lld:pubmed
pubmed-article:1530297pubmed:languagejpnlld:pubmed
pubmed-article:1530297pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1530297pubmed:citationSubsetIMlld:pubmed
pubmed-article:1530297pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1530297pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1530297pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1530297pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1530297pubmed:statusMEDLINElld:pubmed
pubmed-article:1530297pubmed:monthAuglld:pubmed
pubmed-article:1530297pubmed:issn0385-0684lld:pubmed
pubmed-article:1530297pubmed:authorpubmed-author:KoideYYlld:pubmed
pubmed-article:1530297pubmed:authorpubmed-author:OchiaiTTlld:pubmed
pubmed-article:1530297pubmed:authorpubmed-author:MatsushitaKKlld:pubmed
pubmed-article:1530297pubmed:authorpubmed-author:AwanoTTlld:pubmed
pubmed-article:1530297pubmed:authorpubmed-author:MatsubaraHHlld:pubmed
pubmed-article:1530297pubmed:authorpubmed-author:OkuyamaKKlld:pubmed
pubmed-article:1530297pubmed:authorpubmed-author:AmanoHHlld:pubmed
pubmed-article:1530297pubmed:authorpubmed-author:FunamiYYlld:pubmed
pubmed-article:1530297pubmed:authorpubmed-author:TohnosuNNlld:pubmed
pubmed-article:1530297pubmed:authorpubmed-author:NakaichiHHlld:pubmed
pubmed-article:1530297pubmed:issnTypePrintlld:pubmed
pubmed-article:1530297pubmed:volume19lld:pubmed
pubmed-article:1530297pubmed:ownerNLMlld:pubmed
pubmed-article:1530297pubmed:authorsCompleteNlld:pubmed
pubmed-article:1530297pubmed:pagination1511-4lld:pubmed
pubmed-article:1530297pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1530297pubmed:meshHeadingpubmed-meshheading:1530297-...lld:pubmed
pubmed-article:1530297pubmed:meshHeadingpubmed-meshheading:1530297-...lld:pubmed
pubmed-article:1530297pubmed:meshHeadingpubmed-meshheading:1530297-...lld:pubmed
pubmed-article:1530297pubmed:meshHeadingpubmed-meshheading:1530297-...lld:pubmed
pubmed-article:1530297pubmed:meshHeadingpubmed-meshheading:1530297-...lld:pubmed
pubmed-article:1530297pubmed:meshHeadingpubmed-meshheading:1530297-...lld:pubmed
pubmed-article:1530297pubmed:meshHeadingpubmed-meshheading:1530297-...lld:pubmed
pubmed-article:1530297pubmed:meshHeadingpubmed-meshheading:1530297-...lld:pubmed
pubmed-article:1530297pubmed:meshHeadingpubmed-meshheading:1530297-...lld:pubmed
pubmed-article:1530297pubmed:meshHeadingpubmed-meshheading:1530297-...lld:pubmed
pubmed-article:1530297pubmed:meshHeadingpubmed-meshheading:1530297-...lld:pubmed
pubmed-article:1530297pubmed:meshHeadingpubmed-meshheading:1530297-...lld:pubmed
pubmed-article:1530297pubmed:meshHeadingpubmed-meshheading:1530297-...lld:pubmed
pubmed-article:1530297pubmed:year1992lld:pubmed
pubmed-article:1530297pubmed:articleTitle[Signification of liver metastases of colorectal cancer with special reference to recurrence in the residual liver after hepatic resection].lld:pubmed
pubmed-article:1530297pubmed:affiliationDept. of Surgery II, School of Medicine, Chiba University.lld:pubmed
pubmed-article:1530297pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1530297pubmed:publicationTypeEnglish Abstractlld:pubmed